[Blastocystosis: nitazoxanide as a new therapeutic option].

We report a case of a patient with AIDS and severe immunosuppression who developed diarrhea due to a vacuolar stage of Blastocystis hominis. The patient was treated with nitazoxanide, a 5-nitrothiazole broad-spectrum antiparasitic agent. We obtained complete remission of symptoms and eradication of the parasite. Nitazoxanide is a new treatment option for blastocystosis in AIDS patients. Further studies to test its efficacy are needed.
AuthorsSérgio Cimerman, Maria Cecília Teixeira Ladeira, Wilma Assunção Iuliano
JournalRevista da Sociedade Brasileira de Medicina Tropical (Rev Soc Bras Med Trop) 2003 May-Jun Vol. 36 Issue 3 Pg. 415-7 ISSN: 0037-8682 [Print] Brazil
Vernacular TitleBlastocistose: nitazoxanida como nova opção terapêutica.
PMID12908045 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Antiprotozoal Agents
  • Thiazoles
  • nitazoxanide
  • AIDS-Related Opportunistic Infections (diagnosis, drug therapy)
  • Adult
  • Animals
  • Antiprotozoal Agents (therapeutic use)
  • Blastocystis Infections (diagnosis, drug therapy)
  • Blastocystis hominis (isolation & purification)
  • Feces (parasitology)
  • Humans
  • Male
  • Parasite Egg Count
  • Thiazoles (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: